SMECX Mutual Fund

SMECX Mutual Fund

NAV$8.54
See how much of SMECX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
-
Expense Ratio
1.97%
Dividend Yield (Current)
-
Holdings
80
Inception Date
Aug 31, 2000
Fund Family
Invesco (US)
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD+6.66%
1 Year+7.97%
3 Year+13.07%
5 Year+5.00%
10 Year+8.34%

Asset Allocation

Stocks: 95.43%
Cash: 2.64%
Other: 1.93%
See how much of SMECX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
CRLCharles River Laboratories International Inc2.30%
SANMSanmina Corp2.14%
AITApplied Industrial Technologies Inc2.04%
HALOHalozyme Therapeutics Inc2.04%
BTSGBrightspring Health1.93%
Top 10 Concentration: 19.42%Report Date: Aug 31, 2026
Download all 80 holdings for SMECX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Latest Distribution
$2.85
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

SMECX Mutual Fund Overview

SMECX Mutual Fund (Invesco Small Cap Equity Fund Class C) is managed by Invesco (US). SMECX expense ratio is 1.97%, holding 80 positions across sectors including Financials, Industrials, Information Technology. Inception date: 2000-08-31.

SMECX performance shows a YTD return of 6.66%. The 1-year return is 7.97% and the 5-year return is 5.00%.

SMECX top holdings include Charles River Laboratories International Inc (2.3%), Sanmina Corp (2.1%), Applied Industrial Technologies Inc (2.0%), Halozyme Therapeutics Inc (2.0%), Brightspring Health (1.9%). Go to all SMECX holdings, SMECX sectors, or SMECX dividends.

SMECX can be compared against other funds. Use SMECX overlap to find shared positions, or SMECX vs another fund for a side-by-side view. SMECX alternatives are available via the screener, along with tax-loss harvesting opportunities.